Aclarion is showcasing its innovative technology, Nociscan, which is the first evidence-supported SaaS platform designed to assist physicians in distinguishing between painful and nonpainful discs in ...

The increase in the chronic lower back pain market size is a direct consequence of the expected launch of potential therapies, along with great competition among various companies and precision ...

(MENAFN- GlobeNewsWire - Nasdaq) – Encore data to be presented demonstrating that cebranopadol displays significant and sustained pain reduction with a distinguished safety profile following ...